Accretion Pharmaceuticals Limited IPO GMP

Accretion Pharmaceutical Limited is one of the most promising & rising groups in the Healthcare industry with a rich legacy of high-quality healthcare through Ayurveda, Nutraceuticals and Pharmaceutical products. The company has established itself as a conglomerate of 4 strong companies with collective strength of 400+ people and year-on-year progress leading to a constant growth.

Accretion Pharmaceuticals, an Book Built Issue Issue amounting to ₹ 29.75 Crores, consisting entirely an Fresh Issue of 29.46 Lakh Shares. The subscription period for the Accretion Pharmaceuticals IPO opens on May 14, 2025, and closes on May 16, 2025. The allotment is expected to be finalized on or about Monday, May 19, 2025, and the shares will be listed on the NSE SME with a tentative listing date set on or about Wednesday, May 21, 2025.

The Share Price Band of Accretion Pharmaceuticals IPO is set at ₹ 96 to ₹ 101 per equity share. The Market Capitalisation of the Accretion Pharmaceuticals Limited at IPO price of ₹ 101 per equity share will be ₹ 112.27 Crores. The lot size of the IPO is 1,200 shares. Retail investors are required to invest a minimum of ₹ 1,21,200, while the minimum investment for High-Net-Worth Individuals (HNIs) is 2 lots (2,400 shares), amounting to ₹ 2,42,400.

Jawa Capital Services Private Limited is the book running lead manager of the Accretion Pharmaceuticals IPO, while Kfin Technologies Limited is the registrar for the issue. Gretex Share Broking Limited is the Market Maker for Accretion Pharmaceuticals IPO.

Accretion Pharmaceuticals Limited IPO GMP Today
The Grey Market Premium of Accretion Pharmaceuticals Limited IPO is expected to be ₹ 0 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Accretion Pharmaceuticals Limited IPO Live Subscription Status Today: Real-Time Update
As of 07:00 PM on 16 May, 2025, the Accretion Pharmaceuticals Limited IPO live subscription status shows that the IPO subscribed 7.13 times on its Final day of subscription period. Check the Accretion Pharmaceuticals IPO Live Subscription Status Today at NSE.

Accretion Pharmaceuticals IPO Anchor Investors Report
Accretion Pharmaceuticals has raised ₹ 2.13 Crores from Anchor Investors at a price of ₹ 101 per shares in consultation of the Book Running Lead Managers. The company allocated 2,11,200 equity shares to the Anchor Investors. Check Full List of Accretion Pharmaceuticals Anchor Investor List.

Note:- Equity Shares allotted to Anchor Investors (if any) are allotted from Qualified Institutional Buyers (QIBs) reservation portion.
Note:- The Number of shares offered shown IPO subscription section table is calculated at the lower end of the price band and Number of shares calculated in IPO details table section is calculated at upper end of the price band in case of Book Building Issue, so there can be difference. This is because we assume shares will be issued by the company at upper band as Anchor Investors also subscribe at upper band and shares will be issued at lower band only if in case of undersubscription of IPO.
Note:- Market Maker portion (if any) are not shown separately in subscription table and included in NIIs reservation portion

Accretion Pharmaceuticals Limited Day Wise IPO GMP Trend

Accretion Pharmaceuticals Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Accretion Pharmaceuticals IPO allotment date is 19 May, 2025, Monday. Accretion Pharmaceuticals IPO Allotment will be out on 19th May, 2025 and will be live on Registrar Website from the allotment date. Check Kfin Technologies Limited IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Accretion Pharmaceuticals Limited IPO from the dropdown list of IPOs
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Accretion Pharmaceuticals Limited IPO
Accretion Pharmaceuticals proposes to utilise the Net Proceeds towards the following objects: 
a. ₹ 269.73 Lakh is required for Capital expenditure towards purchase of new equipment/machineries, etc.
b. ₹ 465.57 Lakh is required for Capital expenditure towards upgradation of existing manufacturing facility;
c. ₹ 99.17 Lakh is required for Repayment/prepayment of certain borrowings availed by the Company;
d. ₹ 1,468.00 Lakh is required for Funding working capital requirements; and
e. General Corporate Purpose

Refer to Accretion Pharmaceuticals Limited RHP for more details about the Company